MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance

Table 2

Cross-resistance of doxorubicin-resistant cells to other chemotherapeutic agents.

Agents	IC50		value	IC50		value
	Jurkat	Doxorubicin-resistant Jurkat		H9	Doxorubicin-resistant H9
Cisplatin (uM)	6.2 ± 0.3	9.0 ± 0.4	0.0039	5.7 ± 0.3	8.5 ± 0.5	0.0067
Cyclophosphamide (mM)	3.3 ± 0.2	4.8 ± 0.2	0.0056	2.4 ± 0.2	3.9 ± 0.3	0.0106